Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Der Schmerz 13 (1999), S. 196-200 
    ISSN: 1432-2129
    Keywords: Schlüsselwörter Migräne ; Akupunktur ; Alternative Therapiemethoden ; Diagnostik ; Entspannungsverfahren ; Psychotherapie ; Key words Migraine ; Acupuncture ; Paramedical treatment methods ; Diagnostic features ; Relaxation methods ; Psychotherapy
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Abstract Background: Migraine is a common neurological disorder (16% women, 6% men) associated with high direct and indirect costs. We evaluated the diagnostic and paramedical therapeutic measures by estimating the expenditure per patient and the effect of treatment. Methods: A questionnaire was sent to 1000 patients attending the Essen outpatient headache centre in 1995. A total of 293 patients responded, of whom 165 were eligible and could be evaluated. Patients were asked to report diagnostic tests, paramedical treatments applied, average duration of success (defined as meaningfuly reduction in migraine frequency) and costs of paramedical therapy. Results: Paramedical methods of therapy most frequently used were acupuncture, special pads, relaxation methods and herbal therapy. A total of 579 (3.5 on average) diagnostic procedures such as brain or cervical spine CT and MRI or EEG was performed. The average cost for acupuncture was $ 465, while the success was maintained for 3.2 months. $ 1510 was spent on psychotherapy, which was successful for 1.7 months. Patients spent $ 93 for relaxation methods, achieving migraine relief for 7.4 months. Conclusion: Paramedical treatments lack scientific proof, while both acute and prophylactic treatment strategies have been successfully tested in many clinical trials. Paramedical treatment shows a good temporally effect in individual patients.
    Notes: Zusammenfassung Einleitung: Migräne ist eine weit verbreitete (16% aller Frauen, 6% aller Männer) neurologische Erkrankung, die hohe direkte und indirekte Kosten verursacht. Methode: Ziel der Studie war, mittels eines Fragebogens, der an 1000 Patienten, die 1995 die Kopfschmerzambulanz der Uniklinik Essen aufsuchten, verschickt wurde, Auskunft über durchgeführte alternative Therapieverfahren, den damit für die Patienten entstandenen Kosten und den Nutzen (definiert als subjektive Reduktion des Schmerzes oder der Attackenfrequenz) zu erhalten. Weiterhin wurde nach durchgeführten apparativen diagnostischen Verfahren gefragt. Ergebnisse: Die am häufigsten genutzten alternativen Therapieverfahren waren Akupunktur, Lagerungshilfsmittel, Entspannungsverfahren und heilpflanzliche Präparate. 579 diagnostische Verfahren (durchschnittlich 3,5 pro Patient) wie CT und MRT des Kopfs oder EEG wurden durchgeführt. Die durchschnittlichen Kosten für Akupunktur betrugen 791  DM. Der von den Patienten angegebene Erfolg lag hier bei 3,2 Monaten. 2567  DM wurden für Psychotherapie ausgegeben. Die Patienten profitierten lediglich 1,7 Monate von dieser Therapieform. Das Ergebnis zeigt weiterhin, daß die Entspannungsverfahren die beste Kosten-Nutzen-Relation aufweisen (185  DM/7,2 Monate). Schlußfolgerung: Außer für das Muskelrelaxationsverfahren nach Jacobson als Entspannungsverfahren gibt es keinen wissenschaftlichen Nachweis für die Wirksamkeit von alternativen Therapiestrategien. Einzelne Patienten berichten jedoch temporär über Erfolge von alternativen Therapiemöglichkeiten. Die Wirksamkeit schulmedizinischer medikamentöser Verfahren ist durch wissenschaftliche Untersuchungen gut belegt, und die Patienten profitieren bei richtiger Anwendung der Therapieempfehlungen von diesen. Auch für alternative Therapieverfahren muß der wissenschafliche Nachweis der Wirksamkeit gefordert werden.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Journal of neurology 246 (1999), S. 515-519 
    ISSN: 1432-1459
    Keywords: Key words Migraine attack ; 5-HT1B/1D agonists ; Analgesics ; Ergotamine
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Migraine is a paroxysmal disorder characterized by attacks of headache, nausea, vomiting, photophobia, phonophobia, and malaise. This review summarizes new treatment options for therapy of the acute attack. Mild or moderate migraine attacks are treated with antiemetics followed by analgesics such as aspirin, paracetamol, nonsteroidal anti-inflammatory drugs, or antiemetics combined with ergotamine or dihydroergotamine. Sumatriptan, a specific serotonin (5-HT)1B/D agonist is used when attacks do not respond to ergotamine, or when intolerable side effects occur. The new migraine drugs zolmitriptan, naratriptan, rizatriptan, and eletriptan differ slightly in their pharmacological profiles, which translates into minor differences in efficacy, headache recurrence, and side effects. New drugs in migraine prophylaxis include cyclandelate, valproic acid and magnesium.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1432-1459
    Keywords: Migraine ; Cerebral blood flow velocity ; Ergotamine ; Flunarizine ; Sumatriptan
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Changes in the diameter of extracranial and intracranial arteries resulting in changes in cerebral blood flow have previously been assumed to be the most important pathophysiological factor in migraine. To test this hypothesis 20 normal subjects, and three groups of patients (n=29) with migraine were investigated by means of transcranial Doppler sonography. Blood flow velocities in the middle cerebral (MCA) and in basilar (BA) arteries were measured. Data from patients were obtained in the interval between migraine attacks, during migraine attacks and following treatment with either ergotamine (0.5 mg i.m.; n=10); flunarizine, a calcium overload blocker (20 mg i.v.; n=13); or a 5-HT1-like agonist (sumatriptan, 4 mg s.c.; n=6). Ergotamine and sumatriptan are constrictors of cerebral arteries in animal experiments. The arithemtic mean of flow velocity in the BA was reduced in normal subjects (45 cm/s) as compared with patients with migraine measured in between attacks (53 cm/s). Mean flow velocity in MCA was not different in normals (72.5 cm/s) as compared with migraineurs (75 cm/s). Neither ergotamine nor the 5-HT1 agonist and flunarizine resulted in a significant change in blood flow velocity in MCA and BA. This was true irrespective of whether the drugs were given in the headache-free period, during a migraine attack or during the withdrawal phase of drug-induced headache. Ergotamine was effective in improving headache during migraine attacks and sumatriptan attenuated headache during drug withdrawal from chronic analgesic intake. These results indicate that the action of ergotamine and the 5-HT1-receptor agonist is probably not mediated by their vasoconstrictor action on cerebral arteries.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...